Nuvation Bio (NYSE: NUVB) officer prepares $696K share sale

Rhea-AI Filing Summary

Nuvation Bio Inc. (NUVB) is the issuer for which officer Gary Hattersley filed a notice of proposed resale of restricted or control securities under Rule 144. The filing covers 100,000 shares of common stock, held via Morgan Stanley Smith Barney LLC, with an aggregate market value of $696,000.00 and an intended sale date of August 19, 2026, following an exercise of stock options for cash on the same date.

Key Figures

Shares to be sold: 100000 shares Aggregate market value: $696,000.00 Planned sale date: 08/19/2026 +2 more

5 metrics

Shares to be sold 100000 shares Common stock covered by the Rule 144 notice for Gary Hattersley

Aggregate market value $696,000.00 Reported value for the 100,000 Nuvation Bio Inc. common shares

Planned sale date 08/19/2026 Date listed for securities to be sold and stock option exercise

Security type Common Class of Nuvation Bio Inc. stock subject to the Rule 144 filing

Exchange NYSE Listing venue identified for Nuvation Bio Inc. common stock

Key Terms

Rule 144, Exercise of Stock Options, restricted or control securities, Form 144

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Exercise of Stock Options financial

"Common | 08/19/2026 | Exercise of Stock Options | Issuer"

restricted or control securities regulatory

"securities are To Be Sold | GARY HATTERSLEY See the definition of "person""

Form 144 regulatory

"144: Filer Information 144: Issuer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

What does the Form 144 filing mean for NUVB and Gary Hattersley?

The filing states that Gary Hattersley, an officer of Nuvation Bio Inc. (NUVB), may sell 100,000 common shares under Rule 144. It discloses an anticipated sale date of August 19, 2026 after a cash stock option exercise on that date.

How many NUVB shares are covered by this Form 144 notice?

The notice covers 100,000 shares of Nuvation Bio Inc. common stock. These shares are associated with an exercise of stock options for cash on August 19, 2026 and are held in an account at Morgan Stanley Smith Barney LLC.

What is the approximate market value of the NUVB shares in this Form 144?

The filing reports an aggregate market value of $696,000.00 for the 100,000 common shares. This value is based on market information identified by a number labeled 351123233 and ties to the proposed sale date of August 19, 2026.

When are the NUVB shares expected to be sold under this Form 144?

The filing lists August 19, 2026 as the relevant date for the securities to be sold and for the exercise of stock options. This date anchors both the option exercise for cash and the potential resale of the 100,000 shares under Rule 144.

Which broker is involved in the proposed NUVB share sale under Form 144?

The 100,000 NUVB common shares are held through Morgan Stanley Smith Barney LLC Executive Financial Services in New York. This broker is identified as the account through which the Rule 144 resale may occur for Gary Hattersley.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/19/2026 - 04:31 PM Accepted by SEC EDGAR 08/19/2026 - 04:30 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001521111
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Nuvation Bio Inc.
SEC File Number	001-39351
Address of Issuer	1500 Broadway, Suite 1401 New York NEW YORK 10036
Phone	332-208-6102
Name of Person for Whose Account the Securities are To Be Sold	GARY HATTERSLEY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	100000	696000.00	351123233	08/19/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/19/2026	Exercise of Stock Options	Issuer			100000	08/19/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/19/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/04/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gary Hattersley
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)